Missible oil containing oxadiazon and fomesafen and production method thereof
A technology of fomesafen and its production method, which is applied in the field of emulsifiable concentrates containing oxadiazone and fomesafen, can solve the problems of undiscovered literature on the compounding and application of oxadiazone and fomesafen, and achieve the goal of overcoming Effects of weed resistance, pollution reduction, and improved efficacy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0033] The emulsifiable concentrate containing oxadiazone and fomesafen of the present embodiment has the following components and weight content:
[0034] Oxadiazone 25%
[0035] Fomesafen 30%
[0036] Surfactant 10%
[0037] Other functional additives 5%
[0038] Solvent 30%
[0039] The surfactant in this embodiment is a mixture of dispersant and wetting agent. The dispersant is calcium lignosulfonate, with a content of 8%; the wetting agent is sodium lauryl sulfate, with a content of 2%; other functional additives are thickener xanthan gum; the solvent is N,N-dimethyl Formamide and isopropylamine, of which N,N-dimethylformamide content is 15%.
[0040] The production method of the emulsifiable concentrate containing oxadiazone and fomesafen in this embodiment is as follows: the active ingredients oxadiazone and fomesafen are added to the solvent, and surfactants and other functional additives are added therein. Stir in the mixing tank to mix evenly.
Embodiment 2
[0042] The difference between this embodiment and embodiment 1 is: its component and weight content are:
[0043] Oxadiazone 25%
[0044] Fomesafen 4%
[0045] Surfactant 11%
[0046] Other functional additives 5%
[0047] Solvent 55%
[0048] The surfactant in this embodiment is a mixture of dispersant and wetting agent. Dispersant is alkyl naphthalene sulfonate formaldehyde condensate, content 8%; wetting agent is sodium lauryl sulfate, content 3%; other functional additives are thickener xanthan gum; solvent is N, N -Dimethylformamide and ethyl acetate, of which N,N-dimethylformamide content is 30%.
Embodiment 3
[0050]The difference between this embodiment and embodiment 1 is: its component and weight content are:
[0051] Oxadiazone 15%
[0052] Fomesafen 25%
[0053] Surfactant 15%
[0054] Other functional additives 5%
[0055] Solvent 40%
[0056] The surfactant of this embodiment is the mixing of dispersant and emulsifier. The dispersant is polycarboxylate, with a content of 8%; the emulsifier is Nongru BY-125, with a content of 7%; other functional additives are thickener organic bentonite; the solvent is N-methylpyrrolidone and propanol, of which N , N-dimethylformamide content is 20%.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



